You just read:

Tolero Pharmaceuticals Advances Investigational Agent TP-0903 into Phase 1b Expansion Stage of Study in Patients with Advanced Solid Tumors

News provided by

Tolero Pharmaceuticals, Inc.

May 30, 2019, 17:00 ET